Navigation Links
EuroPCR 2014 examines whether science translates into practice with new session format
Date:5/22/2014

22 May 2014, Paris, France: The value of analysing published clinical trials and the benefit of informed discussion were highlighted yesterday when the ACCOAST trial data were discussed in a new session formatWill this trial change my practice? at EuroPCR 2014. ACCOAST trial results demonstrate that pre-treatment with prasugrel in NSTEMI patients undergoing percutaneous coronary intervention (PCI) is inferior to treatment with the drug after angiography. Several other trials are also being scrutinised in the same format, which ends with a discussion with the audience members on whether the trial results would change their practice or not.

Speaking on the value of the session format, panellist Andreas Baumbach, University of Bristol, UK, said: "There is a need to translate what we read in published journals as trials, ie. the science, to what it means for the practitioner on a daily basis. What does it actually mean when a trial says that this treatment is better, or not, than another one. What does this information finally mean for the patient I am treating? This format is trying to get knowledgeable people, including a trialist, to talk about the specifics of the trial as it is published in order to tease out the data from it that are most relevant for our practice."

The session encourages practitioners to compare the population treated in the trial to the population they treat in daily practice. It also encourages practitioners to question whether the technique used is comparable to the one they employ, and to analyse the endpoints that have been chosen in the trial in order to see if they are relevant for patients.

The ACCOAST trial evaluated the effect of administering the P2Y12 antagonist prasugrel at the time of diagnosis versus administering it after the coronary angiography, if percutaneous coronary intervention (PCI) was indicated. Investigators studied 4,033 patients with NSTE acute coronary syndromes and a positive troponin level who were
'/>"/>

Contact: Isabelle Uzielli
iuzielli@europcr.com
EuroPCR
Source:Eurekalert

Page: 1 2

Related medicine news :

1. CRF will Provide updates on several key cardiovascular trials at EuroPCR
2. New ESC-EACTS guidelines on myocardial revascularization to be released at EuroPCR 2014
3. EuroPCR 2014 showcases technological advances in complex cardiovascular interventions
4. Personalizing revascularization strategy for STEMI patients is vital, EuroPCR panel finds
5. Study examines medicare use for Mohs micrographic surgery and surgical excision for skin cancer
6. Study examines drug regimen for the treatment of non-small cell lung cancer among older patients
7. Study examines adverse effects among different radiation therapies for prostate cancer
8. LA BioMeds Dr. John Tsuang examines effects of Ibudilast and metamphetamines
9. Study examines benefit of follow-up CT when abdominal ultrasound inconclusive
10. Research examines when benefits of screening mammography outweigh the harms for women in their 40s
11. Study examines necessity of additional imaging in PET/CT oncologic reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , ... June 30, 2015 , ... ... June 24, 2015 amidst bright skies and inspirational words. , The independent, ... processional walk from the Glenholme building to the school’s Center for the Arts. ...
(Date:6/30/2015)... Falls Church, VA (PRWEB) , ... June 30, ... ... (APNA) 29th Annual Conference will be held October 28-31, 2015 at Disney’s Coronado ... days of continuing nursing education and networking. Each year, this premiere event for ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Americans report ... from the buzzer on Monday mornings, which puts stressed out people right over the ... week, with 22% suffering from sleep deprivation every night. Sleeping pills now lead the ...
(Date:6/30/2015)... CA (PRWEB) , ... June 30, 2015 , ... “It ... and founder of SunGrubbies.com. “We are particularly interested in getting the word out ... take years to surface. We are extremely pleased with our new video ...
(Date:6/29/2015)... ... ... Aespala Medspa and Plastic Surgery is proud to introduce the newest member ... Dreyfuss received his medical degree from Emory University in Atlanta before completing a General ... at the University of Chicago. He has taught and practiced medicine in the Chicago ...
Breaking Medicine News(10 mins):Health News:The Glenholme School Graduates Its Class of 2015 2Health News:The Glenholme School Graduates Its Class of 2015 3Health News:The Glenholme School Graduates Its Class of 2015 4Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 2Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 3Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 2Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 3Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 3Health News:Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office 2Health News:Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office 3
... CHAPEL HILL, N.C., April 4, 2008 Companies ... For a,company with an annual sales volume of ... are assigned to the early-stage commercialization team along,with ... volumes, the ratio is approximately four to three, ...
... are five-to-six times more likely to be at serious risk ... early as their teenage years, according to a new study ... Hill. , The findings, published Friday (April 4) in the ... children twice first while in grade school, then again ...
... More than 54 million American,adults have prediabetes, ... to live,with diabetes and all of its health ... created by Kronos Optimal Health,Company. It is estimated ... with manageable lifestyle choices., "When someone is ...
... but not mother,s, weight and elevated enzymes , , THURSDAY, ... early-onset obesity are at increased risk for elevated liver ... , Researchers evaluated 1,732 children, average age 42, of ... of families in Framingham, Mass. The researchers found that ...
... Two Doses Against the Most ... Rotavirus Types in the U.S., PHILADELPHIA, April 3, ... the U.S. Food and Drug Administration,(FDA) has approved ROTARIX(R) ... in infants. ROTARIX will offer,protection against the most commonly ...
... outcome of ,terrible 2s, battles but not frequency, ... The way mothers and their 2-year-olds relate to each ... -- of conflict during the "terrible twos." And a ... frequency of such conflicts, according to a new study. ...
Cached Medicine News:Health News:Early-stage Commercialization Success: Pharma Companies Adjust Resources in Light of Industry Changes 2Health News:Inactive kids face 6-fold risk of heart disease by teen years, study finds 2Health News:Kronos Optimal Health Company Aims to Stop Diabetes Before It Starts 2Health News:Dads' Early-Onset Obesity Linked to Liver Disease in Kids 2Health News:FDA APPROVES ROTARIX(R) [Rotavirus Vaccine, live, oral], THE FIRST VACCINE LICENSED TO COMPLETE THE ROTAVIRUS IMMUNIZATION SERIES BY FOUR MONTHS OF AGE 2Health News:FDA APPROVES ROTARIX(R) [Rotavirus Vaccine, live, oral], THE FIRST VACCINE LICENSED TO COMPLETE THE ROTAVIRUS IMMUNIZATION SERIES BY FOUR MONTHS OF AGE 3Health News:FDA APPROVES ROTARIX(R) [Rotavirus Vaccine, live, oral], THE FIRST VACCINE LICENSED TO COMPLETE THE ROTAVIRUS IMMUNIZATION SERIES BY FOUR MONTHS OF AGE 4Health News:FDA APPROVES ROTARIX(R) [Rotavirus Vaccine, live, oral], THE FIRST VACCINE LICENSED TO COMPLETE THE ROTAVIRUS IMMUNIZATION SERIES BY FOUR MONTHS OF AGE 5Health News:Mother-Child Bond Affects Quality of Conflict Resolution 2
(Date:6/29/2015)... 29, 2015  New guidelines released today by ... give hope for better outcomes to the hundreds ... ischemic stroke each year. Stryker,s Trevo ® ... in the clinical trials that provided data for ... strongly recommend endovascular therapy with stent retrievers for ...
(Date:6/29/2015)... PAUL, Minn. , June 29, 2015 ... manufacturer of devices that use neuroblocking technology to treat ... that it has commenced an underwritten public offering of ... common stock, Series A warrants to purchase common stock ... whose purchase of units in the offering would result ...
(Date:6/29/2015)... Sciences, Inc. (NASDAQ: ALIM ) (Alimera), a pharmaceutical ... of prescription ophthalmic pharmaceuticals, today announced that Rick ... will present at the 2015 Cantor Fitzgerald Inaugural Healthcare ... at Le Parker Meridien Hotel in New ... webcast live and will be available for access, along ...
Breaking Medicine Technology:New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 3EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 3
... , ATLANTA , Feb. 8 ... an Atlanta -based, biopharmaceutical company developing human vaccines for ... agents, today provided an update on its vaccine trials progress. ... rate, 60,000 new infections annually, and that,s just in ...
... , PORTLAND, Ore. , Feb. 8 ... use of localized content by sales teams. Together, the companies ... translated content to reach the hands of global sales professionals ... sales cycle. This combination gives the sales person the right ...
Cached Medicine Technology:GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA 2GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA 3GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA 4GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA 5GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA 6Prolifiq and viaLanguage Announce Partnership: Accelerate the Use of Localized Content by Sales Teams 2Prolifiq and viaLanguage Announce Partnership: Accelerate the Use of Localized Content by Sales Teams 3
Inquire...
... Tips offer a safe alternative to using ... for applications such as PCR(a), pipetting radioactive ... Tips are excellent for tissue culture, gel ... Tips prevent aerosol contaminants and liquids from ...
... Eliminate aerosol contamination, ... reactions in PCR. Hydrophobic, ... Only air can pass ... tips, in contrast to ...
... Finntip Filters are ideal ... methods, or for any work ... They are designed for pipetting ... samples, and other. For applications ...
Medicine Products: